DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ANAGRELIDE HYDROCHLORIDE

« Back to Dashboard

All Clinical Trials for Anagrelide Hydrochloride

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00175838	Primary Thrombocythaemia 1 Trial	Active, not recruiting	Cambridge University Hospitals NHS Foundation Trust	N/A	1997-07-01	The purpose of this trial is to see if Hydroxyurea + aspirin is a better treatment than aspirin alone for Intermediate Risk Primary Thrombocythemia (PT) patients.
NCT00175838	Primary Thrombocythaemia 1 Trial	Active, not recruiting	Institute of Cancer Research, United Kingdom	N/A	1997-07-01	The purpose of this trial is to see if Hydroxyurea + aspirin is a better treatment than aspirin alone for Intermediate Risk Primary Thrombocythemia (PT) patients.
NCT00175838	Primary Thrombocythaemia 1 Trial	Active, not recruiting	University of Cambridge	N/A	1997-07-01	The purpose of this trial is to see if Hydroxyurea + aspirin is a better treatment than aspirin alone for Intermediate Risk Primary Thrombocythemia (PT) patients.
NCT00202644	A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia Patients	Completed	Shire	Phase 4	2006-01-01	Essential thrombocythaemia is a disorder of bone marrow, which causes too many platelets to be produced. Platelets are small cells carried around in the blood, which help form blood clots. When patients have too many platelets, there is a risk of blood clots forming unnecessarily and excessive bleeding. The aim of this study is to gain additional information on the safety profile of Anagrelide (Xagrid(r)) and Hydroxyurea (also known as hydroxycarbamide).

Clinical Trial Conditions for Anagrelide Hydrochloride

Condition Name

Condition Name for Anagrelide Hydrochloride
Intervention	Trials
Essential Thrombocythemia	5
Essential Thrombocythaemia	4
Healthy	3
High Risk Polycythemia Vera	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Anagrelide Hydrochloride
Intervention	Trials
Thrombocytosis	16
Thrombocythemia, Essential	16
Polycythemia Vera	5
Polycythemia	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Anagrelide Hydrochloride

Trials by Country

Trials by Country for Anagrelide Hydrochloride
Location	Trials
United States	53
Japan	18
Germany	11
France	7
Italy	5

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Anagrelide Hydrochloride
Location	Trials
Pennsylvania	4
California	4
Arizona	4
North Carolina	4
Utah	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Anagrelide Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Anagrelide Hydrochloride
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	7
Phase 2/Phase 3	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Anagrelide Hydrochloride
Clinical Trial Phase	Trials
Completed	10
Recruiting	5
Active, not recruiting	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Anagrelide Hydrochloride

Sponsor Name

Sponsor Name for Anagrelide Hydrochloride
Sponsor	Trials
Shire	6
AOP Orphan Pharmaceuticals AG	3
Roche Pharma AG	3

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Anagrelide Hydrochloride
Sponsor	Trials
Industry	22
Other	12
NIH	2

Export unavailable in trial.
Subscribe for complete access.